| Daniel Peter Weil, MD | |
|
4905 W Tilghman St, Suite 250, Allentown, PA 18104-9130 | |
| (484) 866-9583 | |
| (610) 366-1147 |
| Full Name | Daniel Peter Weil |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 4905 W Tilghman St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174685390 | NPI | - | NPPES |
| 0162922 | Medicaid | NJ | |
| 50077669 | Other | PA | CAPITAL ADVANTAGE |
| 000000242913 | Other | PA | UNISON |
| 1021234600001 | Medicaid | PA | |
| 2022445 | Other | PA | HIGHMARK |
| 823147 | Other | PA | 1ST HEALTH PRIORITY |
| 119185 | Other | PA | GEISINGER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD431077 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
| Lehigh Valley Anesthesia Services, P. C. | 8820992183 | 132 |
News Archive
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
Information relevant to Indiana's current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, "The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and Where Are We Going?"
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 1 days ago
| Entity Name | Lehigh Valley Anesthesia Services, P. C. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730174731 PECOS PAC ID: 8820992183 Enrollment ID: O20031120000076 |
News Archive
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
Information relevant to Indiana's current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, "The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and Where Are We Going?"
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 1 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
Information relevant to Indiana's current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, "The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and Where Are We Going?"
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 1 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
Information relevant to Indiana's current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, "The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and Where Are We Going?"
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Peter Weil, MD 4905 W Tilghman St, Suite 250, Allentown, PA 18104-9130 Ph: (484) 866-9583 | Daniel Peter Weil, MD 4905 W Tilghman St, Suite 250, Allentown, PA 18104-9130 Ph: (484) 866-9583 |
News Archive
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
Information relevant to Indiana's current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, "The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and Where Are We Going?"
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 1 days ago
Jay Soo Jung, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew Street, Allentown, PA 18102 Phone: 610-402-9029 Fax: 610-402-9029 | |
Dr. Melissa Harrison, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1736 W Hamilton St, Allentown, PA 18104 Phone: 610-628-8372 Fax: 610-628-8648 | |
Andrew Newman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 421 Chew St, Allentown, PA 18102 Phone: 610-776-4500 | |
Anthony G. Messina, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 926 N Cedar Crest Blvd Apt B926, Allentown, PA 18104 Phone: 385-313-4170 Fax: 801-303-6556 | |
Michael David Ragusa, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-6164 | |
Robert J. Corba, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 250 Cetronia Road, Allentown, PA 18104 Phone: 610-973-6200 Fax: 610-973-6545 | |
Dr. Aaron Karl Mory, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1736 W Hamilton St, Allentown, PA 18104 Phone: 610-628-8372 Fax: 610-628-8648 |